FTC clears Stryker/Wright Medical as Chopra questions adequacy of compliance monitoring

Ben Remaly

04 November 2020

Credit: Sundry Photography

The Federal Trade Commission has conditionally approved Stryker’s $4 billion purchase of medical device rival Wright Medical, with Commissioner Rohit Chopra urging the agency to adjust how it monitors companies’ compliance with ordered remedies.

Subscribe to Global Competition Review

Subscribe and start reading now

Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.

Subscribe now

Already have access? Login below

Ben Remaly

View full biography

Author | Senior news reporter, Global Competition Review

[email protected]

Tipline

Show us the money: The Tipline for 11 May 2021
Word on the street is that the US antitrust agencies may be receiving a windfall of cash from Congress – and most of the country's 56 other competition enforcers want in on the action. Attorneys general representing 45 states and territories sent a letter on Monday that urged antitrust leadership on Capitol Hill to remember that state antitrust enforcers act as complements to the Federal Trade Commission and the Department of Justice. It appears …
Some kind words: The Tipline for 10 May 2021
Tricky Dick: The Tipline for 7 May 2021

FTC clears Stryker/Wright Medical as Chopra questions adequacy of compliance monitoring

Subscribe to Global Competition Review

Subscribe and start reading now

Already have access? Login below

Related Topics

Ben Remaly